Dr. Onishi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
177 Fort Washington Ave
Mhb 6 Gn435
New York, NY 10032Phone+1 212-305-8923Fax+1 212-305-3035
Education & Training
University of WashingtonResidency, Internal Medicine, 2011 - 2014
University of California San Diego School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2017 - 2026
NY State Medical License 2014 - 2017
WA State Medical License 2013 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsNetwork-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer.Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li
Nature Cancer. 2023-02-01 - 21 citationsVenetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US.Pankit Vachhani, Evelyn M Flahavan, Tao Xu, Esprit Ma, Melissa Montez
The Oncologist. 2022-11-03 - 44 citationsVenetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee
Blood. 2023-03-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
